Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Analysis of Fatigue on Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukaemia

NCT06233890 is registered in ClinicalTrials.gov with Imperial College Healthcare NHS Trust as lead sponsor.

NCT NCT06233890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06233890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Analysis of Fatigue on Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukaemia
Lead sponsor
Imperial College Healthcare NHS Trust
Phase
Observational
Overall status
Unknown status
Start date
May 12, 2023
Completion date
May 12, 2026
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia, chronic myeloid leukemia, chronic phase, fatigue, sleep disturbance